|
|
||||||||
Eur J Cardiothorac Surg 2007;31:756. doi:10.1016/j.ejcts.2007.01.009
Copyright © 2007, European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved
Letters to the Editor |
Alder Hey Royal Children Hospital, Eaton Road, Liverpool L12 2AP, UK
Received 5 December 2006; accepted 8 January 2007.
* Corresponding author. Tel.: +44 151 2525713; fax: +44 151 2525643. (Email: Antonio.Corno{at}rlc.nhs.uk).
Key Words: Cardiopulmonary bypass Congenital heart disease Pediatric Perfusion Surgery
Pouard et al. [1] confirmed the feasibility of normothermic arterial switch, but the Editorial suggested great circumspection [2].
Normothermia in pediatric cardiac surgery, used by Lecompte from 1995 [3,4], is not the only characteristic of normothermic cardiopulmonary bypass (CPB) [1]: other factors need to be considered: flow and hematocrit [4].
Temperature, flow, and hematocrit, should be always considered when analyzing papers comparing only normothermia versus hypothermia [2].
The ongoing debate on advantages of normothermic, high flow, high hematocrit CPB versus conventional techniques is long-lasting in literature and scientific meetings ([2], discussion of ref. [5]).
The arguments against normothermic, high flow, high hematocrit CPB are that newborn infants are more vulnerable to the insult of CPB; there is a greater metabolic demand of the developing organs [2]. The justification for normothermic, high flow, high hematocrit CPB is because infants are more fragile and a more physiological type of perfusion, with temperature, flow, and hematocrit closer to normal physiological values, provides less derangements than a perfusion so far from normality [1,3,4].
The solution to find the answer to the question "what is the best technique for pediatric CPB?" is in prospective randomized clinical trials [2].
Unfortunately a prospective randomized clinical trial doesnt represent a magical solution because of several reasons:
The ideal solution, already proposed (discussion of ref. [5]), is that groups with large experience with deep hypothermia and circulatory arrest or low flow perfusion organize a multi-center prospective randomized clinical trial to compare normothermic, high flow, high hematocrit CPB with hypothermic techniques.
References
This article has been cited by other articles:
![]() |
P. Pouard Reply to Corno Eur. J. Cardiothorac. Surg., April 1, 2007; 31(4): 757 - 757. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |